Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 69-75

  Asanuma, Masato ^a   Miyazaki, Ikuko ^a   Higashi, Youichirou ^a   Tsuji, Takeshi ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Inflammation; Methamphetamine; Profiling

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GROWTH FACTOR; METHAMPHETAMINE; NEUROTRANSMITTER;

ANIMAL CELL; CONFERENCE PAPER; DIFFERENTIAL DISPLAY; DOPAMINERGIC ACTIVITY; DOWN REGULATION; GENE EXPRESSION; INFLAMMATION; METABOLISM; NERVE CELL; NEUROTOXICITY; NONHUMAN; PROTEIN METABOLISM; RAT; SYNAPSE VESICLE;

ANIMALIA;

EID: 10444220272     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.009     Document Type: Conference Paper

References (25)

1. WAGNER, G.C., R.M. CARELLI & M.F. JARVIS. 1985. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Commun. Chem. Pathol. Pharmacol. 47: 221-228.
2. DE VITO, M.J. & G.C. WAGNER. 1989. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28: 1145-1150.
3. CUBELLS, J.F., S. RAYPORT, G. RAJNDRON, et al. 1994. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14: 2260-2271.
4. GIOVANNI, A., L.P. LIANG, T.G. HASTINGS, et al. 1995. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64: 1819-1825.
5. CADET, J.L. & C. BRANNOCK. 1998. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32: 117-131.
6. CADET, J.L., P. SHENG, S. ALI, et al. 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62: 380-383.
7. HIRATA, H., B. LADENHEIM, E. CARLSON, et al. 1996. Autoradiographic evidence for methamphetamine induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714: 95-103.
8. HIRATA, H. & J.L. CADET. 1997. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies. J. Neurochem. 69: 780-790.
9. WU, H. & G. LOZANO. 1994. NF-κB activation of p53: a potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269: 20067-20074.
10. ASANUMA, M. & J.L. CADET. 1998. Methamphetamine-induced increase in striatal NF-κB DNA-binding activity is attenuated in superoxide dismutase transgenic mice. Mol. Brain Res. 60: 305-309.
11. ASANUMA, M., I. MIYAZAKI, Y. HIGASHI, et al. 2002. Methamphetamine- induced increase in striatal p53 DNA-binding activity is attenuated in Cu,Zn-superoxide dismutase transgenic mice. Neurosci. Lett. 325: 191-194.
12. SONSALLA, P.K., W.J. NICKLAS & R.E. HEIKKILA. 1989. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400.
13. SONSALLA, P.K., J.W. GIBB & G.R. HANSON. 1986. Role of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J. Pharmacol. Exp. Ther. 238: 932-937.
14. ASANUMA, M., T. HAYASHI, S.V. ORDONÈZ, et al. 2000. Direct interaction of methamphetamine with the nucleus. Mol. Brain Res. 80: 237-243.
15. O'NEILL, L.A.J. & C. KALTSCHMIDT. 1997. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20: 252-258.
16. ITZHAK, Y. & S.F. ALI. 1996. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67: 1770-1773.
17. IMAM, S.Z., G.D. NEWPORT, Y. ITZHAK, et al. 2001. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J. Neurochem. 76: 745-749.
18. KITA, T., K. SHIMADA, Y. MASTUNARI, et al. 2000. Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB/c mice. Neuropharmacology 39: 399-406.
19. AEBERHARD, E.E., S.A. HENDERSON, N.S. ARABOLOS, et al. 1995. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 208: 1053-1059.
20. DU, Z.Y. & X.Y. LI. 1999. Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro. Int. J. Immunopharmacol. 21: 219-225.
21. ASANUMA, M., S. NISHIBAYASHI-ASANUMA, I. MIYAZAKI, et al. 2001. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem. 76: 1895-1904.
22. ASANUMA, M., H. HIRATA & J.L. CADET. 1998. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience 85: 907-917.
23. CADET, J.L., S. JAYANTHI, M.T. MCCOY, et al. 2001. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse 41: 40-48.
24. YAMAGUCHI, T., Y. KURAISHI, M. MINAMI, et al. 1991. Methamphetamine- induced expression of interleukin-1β mRNA in the rat hypothalamus. Neurosci. Lett. 128: 90-92.
25. LADENHEIM, B., I.N. KRASNOVA, X. DENG, et al. 2000. Methamphetamine- induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 58: 1247-1256.